Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556891 · ClinicalTrials.gov registry record · NA
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
A NA study, sponsored by Valencia Technologies Corporation.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT03556891 is a NA study that has completed, run by Valencia Technologies Corporation. The registered enrollment target is 133 participants.
The verdict
NCT03556891, a NA study, has completed, sponsored by Valencia Technologies Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
This trial is a prospective, multicenter, single-arm study of the safety and effectiveness of eCoinTM tibial nerve stimulation in subjects having overactive bladder (OAB) with urgency urinary incontinence (UUI). The study will evaluate changes from baseline in OAB symptoms as measured by voiding diaries and patient reported-outcomes through 48 weeks of eCoinTM therapy or 52 weeks of implantation.
Interventions
- DEVICE eCoin Tibial Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2024-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03556891
The ClinicalTrials.gov registry entry for NCT03556891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valencia Technologies Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eCoin Tibial Nerve Stimulation is the first listed.
NCT03556891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03556891 about?
NCT03556891 is a clinical study titled "Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence". This trial is a prospective, multicenter, single-arm study of the safety and effectiveness of eCoinTM tibial nerve stimulation in subjects having overactive bladder (OAB) with urgency urinary incontinence (UUI). The study will evaluate changes from baseline in OAB symptoms as measured by voiding dia...
What is the current status of trial NCT03556891?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2018-09-04. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT03556891?
The interventions under investigation include: eCoin Tibial Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03556891?
This trial is sponsored by Valencia Technologies Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.